A revolutionary cancer treatment could transform autoimmune disease

Jan Janisch-Hanzlik, a 49-year-old multiple sclerosis patient, participated in a CAR T cell therapy trial at the University of Nebraska Medical Center, which aims to transform autoimmune disease treatment by reprogramming immune cells. The therapy, originally designed for cancer, is being tested in hundreds of clinical trials for conditions like lupus and Graves' disease. If successful, it could reset the body's defenses to a pre-disease state.